Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients
- Registration Number
- NCT00847314
- Lead Sponsor
- Bayer
- Brief Summary
With advancing age testosterone levels decline in men. Low testosterone levels plus certain symptoms are called "Late Onset Hypogonadism (LOH)". Adipose tissue may contribute to testosterone deficiency. On the other hand testosterone deficiency again leads to a decrease in lean body mass and an increase in fat mass - one of the clinical signs / symptoms of LOH. Lifestyle changes (diet, exercise) alone or in combination with testosterone replacement (TRT), have an influence on the symptoms of LOH. The aim of this study is to assess the additional impact of TRT on Aging Male Symptom Score (AMS) and adiposity (waist circumference) in patients, who are on a diet and exercise program.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
- Male patients > 35yrs
- Waist Circumference > 102cm
- Clinically and biochemically confirmed hypogonadism (testosterone group)
- Willingness to attempt weight optimization
Read More
Exclusion Criteria
- Androgen dependent carcinoma of the prostate or male mammary gland, past or present history of liver tumours
- hypersensitivity towards the active pharmaceutical ingredient or other ingredients.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 1 Testosterone Undeconate (Nebido-R, BAY86-5037) -
- Primary Outcome Measures
Name Time Method Waist Circumference At each visit
- Secondary Outcome Measures
Name Time Method